查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1970840

醫藥物流市場－全球產業規模、佔有率、趨勢、機會、預測：按類型、按組件、按地區和競爭對手分類，2021-2031年

Pharmaceutical Logistics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Component, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球醫藥物流市場預計將從 2025 年的 948.8 億美元成長到 2031 年的 1,435.9 億美元，複合年成長率為 7.15%。

該市場涵蓋醫療產品的採購、倉儲和運輸的專業管理，確保產品從生產到最終使用的完整性和有效性。推動這一市場成長的關鍵因素包括：全球對溫度生物製藥和疫苗的需求不斷成長，這些產品需要精準的低溫運輸管理；以及嚴格的藥品良好分銷規範 (GDP) 法規要求提高供應鏈的安全性和可追溯性。

市場概覽
預測期 2027-2031
市場規模：2025年 948.8億美元
市場規模：2031年 1435.9億美元
複合年成長率：2026-2031年 7.15%
成長最快的細分市場 低溫運輸物流
最大的市場 北美洲

例如，醫療保健分銷商聯盟 (HDA) 的報告顯示，到 2024 年，美國藥品經銷商的銷售額將成長 10.4%，達到 8,620 億美元，這凸顯了物流網路面臨的日益成長的壓力。儘管如此，由於不同國際司法管轄區的監管碎片化，該市場仍面臨許多障礙。這種複雜性造成了合規瓶頸，並增加了跨境運輸的營運成本，從而阻礙了市場的進一步擴張。

市場促進因素

對溫控生物製藥和特種藥品的需求激增正在改變市場格局，這要求物流供應商提升處理高以金額為準、易變化合物的能力。與傳統的小分子藥物不同，單株抗體和基因療法等先進醫療手段需要在整個價值鏈中嚴格控制溫度，以防止劣化。隨著這一轉變促使製造商將產品完整性置於首位，專業低溫運輸空運貨物的處理量正在顯著成長。例如，IAG Cargo報告稱，其2024年恆溫運輸產品的處理量年增22%，凸顯了業界對精準運輸解決方案日益成長的需求。

同時，擴大全球低溫運輸基礎設施和溫控物流已成為當務之急，製造商擴大將這些複雜的營運外包給專業的第三方物流(3PL) 服務商。為了滿足現代醫療產品嚴格的儲存要求，領先的物流整合商正積極拓展其全球業務，建造符合良好分銷規範 (GDP) 的設施。例如，UPS 於 2024 年 9 月確認，其醫療保健網路目前已覆蓋 1,700 萬平方英尺的合規配送空間。基礎設施的擴張支撐著蓬勃發展的物流環境，國際航空運輸協會 (IATA) 的報告也印證了這一點：2024 年全球航空貨運需求增加了 11.3%。這凸顯了跨境醫藥供應鏈貿易的強勁發展動能。

市場挑戰

不同國際司法管轄區監管規定的碎片化，對全球醫藥物流市場的成長構成重大障礙。物流業者必須應對各國在藥品良好分銷規範 (GDP)、序列化和進出口通訊協定方面的複雜差異，這導致管理負擔沉重，營運效率降低。這種分散化迫使企業維護多套合規體系，並投入大量資源來滿足各種文件要求，直接增加跨國貿易成本，並在海關入境口岸造成嚴重擁擠。

這些監管壁壘造成了實際的營運摩擦，阻礙了全球供應鏈的順暢運作。 2025年，醫療保健分銷商聯盟（HDA）指出，複雜的追溯規則導致批發商發現約2%的序列化藥品存在數據差異，而解決這些問題往往需要數週時間。此類與合規性相關的延誤會擾亂庫存管理，迫使物流網路增加安全庫存，從而增加營運資金需求，並限制市場的整體成長潛力。

市場趨勢

倉儲自動化和機器人流程整合正成為物流供應商應對勞動力短缺和提升醫藥供應鏈營運效率的關鍵策略。引入自主移動機器人 (AMR) 和自動化倉儲系統，能夠有效管理醫療試劑盒和臨床試驗材料的複雜揀選需求，減少人為錯誤，並提高處理能力。 DHL 集團等產業領導企業正積極實踐這項技術主導的效率提升趨勢。 2025 年 7 月，DHL 集團宣布投資 5.5 億英鎊，用於擴展其自動化基礎設施，並部署 1,000 多台新機器人，以支援生命科學領域的蓬勃發展。

同時，隨著製藥業將低溫運輸營運與永續性目標相契合，可重複使用的溫控包裝的應用也日益增多。與一次性被動式系統不同，這些主動式可重複使用包裝能夠為高價值貨物提供更優異的溫度穩定性，並透過循環物流網路減少範圍3的排放。 Envilotainor 2025年4月發布的報告重點強調了這一轉變，該報告顯示，2024年藥品出貨量年增8.9%。這反映了製藥業正在向永續的循環包裝解決方案轉型，以最大限度地減少廢棄物和碳排放。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球醫藥物流市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 按類型（低溫運輸物流、非低溫運輸物流）
    • 按組件（儲存組件、傳輸組件和監控組件）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美醫藥物流市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲醫藥物流市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區醫藥物流市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東與非洲醫學流市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美醫藥物流市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球醫藥物流市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • DHL Life Sciences
  • UPS Healthcare
  • FedEx
  • Kuehne+Nagel
  • Deutsche Post DHL
  • DB Schenker
  • Ceva Logistics
  • Agility Logistics
  • Marken
  • AmerisourceBergen

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 25437

The Global Pharmaceutical Logistics Market is projected to expand from USD 94.88 Billion in 2025 to USD 143.59 Billion by 2031, registering a CAGR of 7.15%. This market involves the specialized management of procurement, warehousing, and transportation for medical products, ensuring their integrity and efficacy from production to end-use. Key drivers fueling this growth include the increasing global demand for temperature-sensitive biologics and vaccines, which necessitates precise cold chain handling, along with strict Good Distribution Practice regulations that require enhanced security and traceability within the supply chain.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 94.88 Billion
Market Size 2031USD 143.59 Billion
CAGR 2026-20317.15%
Fastest Growing SegmentCold Chain Logistics
Largest MarketNorth America

Illustrating the growing pressure on these logistics networks, the Healthcare Distribution Alliance reported that sales through U.S. pharmaceutical distributors rose by 10.4 percent to reach $862 billion in 2024. Despite this growth, the market faces a substantial obstacle in the form of regulatory fragmentation across various international jurisdictions. This complexity leads to compliance bottlenecks and elevates operational costs for cross-border shipments, thereby hindering broader market expansion.

Market Driver

The surge in demand for temperature-sensitive biologics and specialty medicines is transforming the market, necessitating that logistics providers enhance their handling capabilities for high-value, unstable compounds. Unlike conventional small-molecule drugs, advanced therapies such as monoclonal antibodies and gene treatments demand rigorous temperature control throughout the supply chain to prevent spoilage. This shift has led to a notable increase in volume for specialized cold-chain air freight, as manufacturers prioritize product integrity; for example, IAG Cargo reported a 22 percent year-on-year tonnage increase for its Constant Climate product in 2024, highlighting the industry's growing need for precise transport solutions.

simultaneously, the expansion of global cold chain infrastructure and cryogenic logistics has become a priority, with manufacturers increasingly outsourcing these complex operations to specialized Third-Party Logistics (3PL) providers. To meet the strict storage needs of modern medical products, major logistics integrators are aggressively expanding their global presence with Good Distribution Practice (GDP) compliant facilities. UPS, for instance, confirmed in September 2024 that its healthcare network now includes 17 million square feet of compliant distribution space. This infrastructure growth supports a bustling logistics environment, evidenced by the International Air Transport Association's report of an 11.3 percent rise in global air cargo demand in 2024, underscoring the strong cross-border trade momentum within the pharmaceutical supply chain.

Market Challenge

Regulatory fragmentation across diverse international jurisdictions presents a significant barrier to the growth of the Global Pharmaceutical Logistics Market. Logistics providers must navigate a complex array of differing national standards regarding Good Distribution Practice (GDP), serialization, and import-export protocols, which creates compounded administrative burdens that reduce operational efficiency. This fragmentation compels companies to maintain multiple compliance systems and allocate considerable resources to varying documentation requirements, directly raising the cost of cross-border trade and causing severe bottlenecks at customs entry points.

These regulatory obstacles create tangible operational friction that hampers the fluidity of global supply chains. In 2025, the Healthcare Distribution Alliance noted that wholesalers found data discrepancies in approximately 2 percent of serialized pharmaceutical products due to complex traceability rules, with resolutions often taking weeks. Such compliance-related delays disrupt inventory management and force logistics networks to hold larger safety stocks, inflating working capital needs and restricting the market's overall growth potential.

Market Trends

Warehouse automation and the integration of robotic processes are becoming essential strategies for logistics providers seeking to address labor shortages and improve operational accuracy in the pharmaceutical supply chain. By deploying autonomous mobile robots (AMRs) and automated storage systems, companies can better manage the complex picking requirements for medical kits and clinical trial supplies, thereby reducing human error and boosting throughput. This trend toward technology-driven efficiency is demonstrated by major players like DHL Group, which announced a £550 million investment in July 2025 to expand its automated infrastructure and introduce over 1,000 new robots to support the growing life sciences sector.

Concurrently, the adoption of reusable temperature-controlled packaging is increasing as the industry aligns cold chain operations with sustainability targets. Unlike single-use passive systems, these active reusable containers provide superior temperature stability for high-value shipments and reduce Scope 3 emissions through circular logistics networks. This shift is highlighted by Envirotainer's April 2025 report, which recorded an 8.9 percent year-on-year increase in shipments for 2024, reflecting the pharmaceutical sector's move toward sustainable, circular packaging solutions to minimize waste and carbon impact.

Key Market Players

  • DHL Life Sciences
  • UPS Healthcare
  • FedEx
  • Kuehne+Nagel
  • Deutsche Post DHL
  • DB Schenker
  • Ceva Logistics
  • Agility Logistics
  • Marken
  • AmerisourceBergen

Report Scope

In this report, the Global Pharmaceutical Logistics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pharmaceutical Logistics Market, By Type

  • Cold Chain Logistics
  • Non-Cold Chain Logistics

Pharmaceutical Logistics Market, By Component

  • Storage
  • Transportation
  • Monitoring components

Pharmaceutical Logistics Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Pharmaceutical Logistics Market.

Available Customizations:

Global Pharmaceutical Logistics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Pharmaceutical Logistics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Cold Chain Logistics, Non-Cold Chain Logistics)
    • 5.2.2. By Component (Storage, Transportation, Monitoring components)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Pharmaceutical Logistics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Component
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Pharmaceutical Logistics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Component
    • 6.3.2. Canada Pharmaceutical Logistics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Component
    • 6.3.3. Mexico Pharmaceutical Logistics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Component

7. Europe Pharmaceutical Logistics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Component
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Pharmaceutical Logistics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Component
    • 7.3.2. France Pharmaceutical Logistics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Component
    • 7.3.3. United Kingdom Pharmaceutical Logistics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Component
    • 7.3.4. Italy Pharmaceutical Logistics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Component
    • 7.3.5. Spain Pharmaceutical Logistics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Component

8. Asia Pacific Pharmaceutical Logistics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Component
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Pharmaceutical Logistics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Component
    • 8.3.2. India Pharmaceutical Logistics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Component
    • 8.3.3. Japan Pharmaceutical Logistics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Component
    • 8.3.4. South Korea Pharmaceutical Logistics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Component
    • 8.3.5. Australia Pharmaceutical Logistics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Component

9. Middle East & Africa Pharmaceutical Logistics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Component
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Pharmaceutical Logistics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Component
    • 9.3.2. UAE Pharmaceutical Logistics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Component
    • 9.3.3. South Africa Pharmaceutical Logistics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Component

10. South America Pharmaceutical Logistics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Component
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Pharmaceutical Logistics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Component
    • 10.3.2. Colombia Pharmaceutical Logistics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Component
    • 10.3.3. Argentina Pharmaceutical Logistics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Component

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Pharmaceutical Logistics Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. DHL Life Sciences
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. UPS Healthcare
  • 15.3. FedEx
  • 15.4. Kuehne+Nagel
  • 15.5. Deutsche Post DHL
  • 15.6. DB Schenker
  • 15.7. Ceva Logistics
  • 15.8. Agility Logistics
  • 15.9. Marken
  • 15.10. AmerisourceBergen

16. Strategic Recommendations

17. About Us & Disclaimer